Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues
This study has been completed.
Information provided by:
First received: March 26, 2012
Last updated: April 23, 2012
Last verified: April 2012
This study is conducted in Europe. The aim of this study is to investigate psychosocial factors related to compliance with treatment with biphasic insulin analogues.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Novo Nordisk:
Primary Outcome Measures:
- Frequency and level of difficulty in introducing changes in compliance with the guidelines for biphasic insulin analogue use in subjects previously treated with biphasic human insulins [ Time Frame: Up to 3 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Correlations between the difficulty in introducing changes in compliance with the guidelines for biphasic insulin analogue use in subjects previously treated with biphasic human insulins, and psychosocial factors [ Time Frame: Up to 3 months ] [ Designated as safety issue: No ]
|Study Start Date:||September 2010|
|Study Completion Date:||December 2010|
|Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|
Other: No treatment given
Patients to complete the "WHO-5 Well-being Index" questionnaireOther: No treatment given
Physicians to complete two questionnaires, "Demographic Data and Disease and Treatment Course" and "Questionnaire of Potential Difficulties in the Period of Treatment Switching from Insulin to Its Analogues"
Contacts and Locations